SARASOTA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics, today announced fourth quarter and full year 2024 financial results. Q4 2024 Financial Highlights (all metrics compared to Q4 2023 unless otherwise noted) Revenue was $1,685,966, an increase of 22% compared to $1
Caterpillar said Wednesday it anticipates that tariffs may increase its second-quarter costs by up to $350 million as its first-quarter sales slipped on declining demand for its equipment. On Tuesday Trump signed an order relaxing some U.S. tariffs on imports of autos and auto parts. In the first quarter, Caterpillar's revenue dropped to $14.25 billion from $15.8 billion a year earlier.
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets started the year with a rally due to optimism about a strong economy and expectations of moderating inflation and lower interest rates. However, concerns over slowing earnings from major Technology companies, geopolitical […]
Stock futures dipped further after the latest update on payrolls from ADP came in well below expectations. Dow futures were down 0.2%. S&P 500 futures were down 0.6%. Nasdaq 100 futures were down 1%. ADP said private businesses added 62,000 jobs in April, down from 147,000 in March and below expectations at 134,000, according to FactSet.
OK